Cha Medical begins construction of $250M Cell Gene Biobank facility
Cha Medical & Bio Group has begun construction of its Cell Gene Biobank facility in Pangyo, South Korea. The facility will be a 710,000 sq ft manufacturing site for cell and gene therapies, as well as a site for stem cell biobanking. The $250 million project is expected to be completed by the end of 2024, the company said. Read More
Vita Therapeutics bolsters leadership
Cell engineering firm Vita Therapeutics has added three new senior vice presidents to its executive lineup. Read More
Curiox Biosystems closes $15M funding round
Curiox Biosystems has completed a $15 million series C financing round. Read More
Berkeley Lab offers CRAGE kit for genome engineering
Lawrence Berkeley National Laboratory (Berkeley Lab) is offering a trial kit for its chassis-independent, recombinase-assisted, genome engineering (CRAGE) tool. Read More
Fujifilm acquires Shenandoah Biotechnology
Fujifilm Irvine Scientific has acquired recombinant protein manufacturer Shenandoah Biotechnology in a deal aimed at broadening its capabilities to support life science research, discovery, and cell and gene therapy. Read More
USCAP 2022: 4 tips for a more sustainable lab
LOS ANGELES -- The global biotechnology and pharmaceutical industry has a carbon footprint greater than even the forestry or paper industry, but there are ways scientists can help decrease their environmental impact, according to a keynote lecture at this week's United States and Canadian Academy of Pathology (USCAP) 2022 meeting. Read More
Organizations invest in stem cell research using unique approaches
Stem cell technology is increasingly being used and developed for a variety of therapeutic purposes, most notably for the treatment of damaged tissue. While these treatments have significant clinical potential, they also require extensive research and investment to support the development of these novel therapies. Read More
Axion BioSystems acquires Cytosmart Technologies
Life sciences firm Axion BioSystems has acquired Netherlands-based Cytosmart, a company specializing in kinetic live-cell imaging analysis. Read More
Video report from BioProcess International US West
What were the hot topics at the BioProcess International US West conference in San Diego? Science Advisory Board account executive Stacey Chopskie offers a report from this important life sciences meeting. Read More
Viral vector manufacturing opens doors to new and innovative therapies
The use of viral vectors has gained significant traction in recent years with many companies implementing and expanding on such technologies. Exothera, Novartis, and Ray Therapeutics are some of the companies that have directly invested in the expansion of viral vector technologies, according to Cell and Gene Therapy Business Outlook, a sister publication of ScienceBoard. Read More
Conferences
International Society for Cell and Gene Therapy Annual Meeting
May 4 - June 7
San Francisco, California United States
Interphex 2022 Conference
May 24-26
New York, New York United States
American Society for Mass Spectrometry Annual Conference
June 5-9
Minneapolis, Minnesota United States
American Society for Microbiology Microbe Meeting
June 9-13
District of Columbia United States
HPLC 2022
June 18-23
San Diego, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter